Ryan David Rose

Dr. Ryan David Rose

The University of Adelaide, Adelaide, South Australia, Australia
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2021 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
TTTiffany C Y Tan
Tiffany C Y Tan
SMSaabah Mahbub
Saabah Mahbub
JCJared Campbell
Jared Campbell
AHAbbas Habibalahi
Abbas Habibalahi
CCCarl A Campugan
Carl A Campugan
KDKylie R Dunning
Kylie R Dunning
Can label-free, non-invasive optical imaging by hyperspectral autofluorescence microscopy discern between euploid and aneuploid cells within the inner cell mass (ICM) of the mouse preimplantation embryo? Hyperspectral autofluorescence microscopy enables discrimination between euploid and aneuploid ICM in mouse embryos. Euploid/aneuploid mosaicism affects up to 17.3% of human blastocyst embryos with trophectoderm biopsy or spent media currently utilized to diagnose aneuploidy and mosaicism in clinical in vitro fertilization. Based on their design, these approaches will fail to diagnose the presence or proportion of aneuploid cells within the foetal lineage ICM of some blastocyst embryos. The impact of aneuploidy on cellular autofluorescence and metabolism of primary human fibroblast cells and mouse embryos was assessed using a fluorescence microscope adapted for imaging with multiple spectral channels (hyperspectral imaging). Primary human fibroblast cells with known ploidy were subjected to hyperspectral imaging to record native cell fluorescence (4–6 independent replicates, euploid n = 467; aneuploid n = 969). For mouse embryos, blastomeres from the eight-cell stage (five independent replicates: control n = 39; reversine n = 44) and chimeric blastocysts (eight independent replicates: control n = 34; reversine n = 34; 1:1 (control:reversine) n = 30 and 1:3 (control:reversine) n = 37) were utilized for hyperspectral imaging. The ICM from control and reversine-treated embryos were mechanically dissected and their karyotype confirmed by whole genome sequencing (n = 13 euploid and n = 9 aneuploid). Two models were employed: (i) primary human fibroblasts with known karyotype and (ii) a mouse model of embryo aneuploidy where mouse embryos were treated with reversine, a reversible spindle assembly checkpoint inhibitor, during the four- to eight-cell division. Individual blastomeres were dissociated from control and reversine-treated eight-cell embryos and either imaged directly or used to generate chimeric blastocysts with differing ratios of control:reversine-treated cells. Individual blastomeres and embryos were interrogated by hyperspectral imaging. Changes in cellular metabolism were determined by quantification of metabolic co-factors (inferred from their autofluorescence signature): NAD(P)H and flavins with the subsequent calculation of the optical redox ratio (ORR: flavins/[NAD(P)H + flavins]). Autofluorescence signals obtained from hyperspectral imaging were examined mathematically to extract features from each cell/blastomere/ICM. This was used to discriminate between different cell populations. An increase in the relative abundance of NAD(P)H and decrease in flavins led to a significant reduction in the ORR for aneuploid cells in primary human fibroblasts and reversine-treated mouse blastomeres (P < 0.05). Mathematical analysis of endogenous cell autofluorescence achieved separation between (i) euploid and aneuploid primary human fibroblast cells, (ii) control and reversine-treated mouse blastomeres cells, (iii) control and reversine-treated chimeric blastocysts, (iv) 1:1 and 1:3 chimeric blastocysts and (v) confirmed euploid and aneuploid ICM from mouse blastocysts. The accuracy of these separations was supported by receiver operating characteristic curves with areas under the curve of 0.97, 0.99, 0.87, 0.88 and 0.93, respectively. We believe that the role of chance is low as mathematical features separated euploid from aneuploid in both human fibroblasts and ICM of mouse blastocysts. N/A. Although we were able to discriminate between euploid and aneuploid ICM in mouse blastocysts, confirmation of this approach in human embryos is required. While we show this approach is safe in mouse, further validation is required in large animal species prior to implementation in a clinical setting. We have developed an original, accurate and non-invasive optical approach to assess aneuploidy within the ICM of mouse embryos in the absence of fluorescent tags. Hyperspectral autofluorescence imaging was able to discriminate between euploid and aneuploid human fibroblast and mouse blastocysts (ICM). This approach may potentially lead to a new diagnostic for embryo analysis. K.R.D. is supported by a Mid-Career Fellowship from the Hospital Research Foundation (C-MCF-58-2019). This study was funded by the Australian Research Council Centre of Excellence for Nanoscale Biophotonics (CE140100003) and the National Health and Medical Research Council (APP2003786). The authors declare that there is no conflict of interest.

14 September 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
MGMacarena Gonzalez
Macarena Gonzalez
TPTanisha Prashar
Tanisha Prashar
HCHaley Connaughton
Haley Connaughton
MBMichael Barry
Michael Barry
RRRebecca Robker
Rebecca Robker
Ryan David RoseRyan David Rose
Ryan David Rose
While critical for male fertility preservation, cryopreservation damage reduces sperm quality and fertilization potential. This study investigated whether the addition of mitochondrial-targeted, antioxidant compounds, also known as Mitochondrial activators, to the cryopreservation medium could protect sperm quality during cryopreservation. For this, semen samples from men undergoing IVF/ICSI treatment, which were donated for research, underwent cryopreservation in the absence or presence of BGP-15, MitoQ and L-carnitine. Fresh semen and thawed sperm samples from the same participant were analyzed for indicators of sperm quality: sperm viability, kinetics, mitochondrial reactive oxygen species (ROS) levels, Mitochondrial Membrane Potential (MMP) and DNA damage. Cryopreservation significantly reduced sperm viability and motility and predicted mucous penetration. BGP-15, MitoQ and L-carnitine improved sperm motility, whilst the addition of L-Carnitine prevented the loss of sperm viability during cryopreservation. Both BGP-15 and L-carnitine reduced sperm DNA oxidative damage, but only BGP-15 significantly reduced DNA fragmentation. More importantly, BGP-15 increased sperm predictive mucous penetration and MMP and reduced DNA oxidation. Our results show that the addition of BGP-15 or L-carnitine to the cryopreservation medium improves sperm quality post-thawing, highlighting the potential of mitochondrial antioxidants to improve long-term fertility preservation in males.

14 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYasmyn Ellaynah Winstanley
Yasmyn Ellaynah Winstanley
Ryan David RoseRyan David Rose
Ryan David Rose
ASAlexander P. Sobinoff
Alexander P. Sobinoff
LWLinda L. Wu
Linda L. Wu
DADeepak Adhikari
Deepak Adhikari
RRRebecca Robker
Rebecca Robker
The initial setting of telomere length during early life in each individual has a major influence on lifetime risk of aging-associated diseases; however there is limited knowledge of biological signals that regulate inheritance of telomere length, and whether it is modifiable is not known. We now show that when mitochondrial activity is disrupted in mouse zygotes, via exposure to 20% O2 or rotenone, telomere elongation between the 8-cell and blastocyst stage is impaired, with shorter telomeres apparent in the pluripotent Inner Cell Mass (ICM) and persisting after organogenesis. Identical defects of elevated mtROS in zygotes followed by impaired telomere elongation, occurred with maternal obesity or advanced age. We further demonstrate that telomere elongation during ICM formation is controlled by mitochondrial-nuclear communication at fertilization. Using mitochondrially-targeted therapeutics (BGP-15, MitoQ, SS-31, metformin) we demonstrate that it is possible to modulate the preimplantation telomere resetting process and restore deficiencies in neonatal telomere length.

30 May 2021 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MLMegan Lim
Megan Lim
HBHannah M. Brown
Hannah M. Brown
Ryan David RoseRyan David Rose
Ryan David Rose
JTJeremy G. Thompson
Jeremy G. Thompson
KDKylie R. Dunning
Kylie R. Dunning

1 May 2020 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
Ryan David RoseRyan David Rose
Ryan David Rose
MBMichael F. Barry
Michael F. Barry
EDEmma V. Dunstan
Emma V. Dunstan
SYSiu Man Yuen
Siu Man Yuen
LCLyndal P. Cameron
Lyndal P. Cameron
MHM. Louise Hull
M. Louise Hull

26 April 2026 in Human Reproduction
Verified
Journal Article
Open access
TLTong Li
Tong Li
DCDarren J X Chow
Darren J X Chow
SLShan Li
Shan Li
Ryan David RoseRyan David Rose
Ryan David Rose
TTTiffany C Y Tan
Tiffany C Y Tan
KDKylie R Dunning
Kylie R Dunning
STUDY QUESTION: What is the impact of one, two, or three vitrification–warming cycles on embryo viability, implantation potential, and post-transfer development compared with fresh transfer? SUMMARY ANSWER: Repeated vitrification–warming cycles progressively impaired embryo cryosurvival, blastocyst quality, and foetal growth after two or more cycles. WHAT IS KNOWN ALREADY: Cryopreservation is central to embryo storage and preimplantation genetic testing, where embryos are biopsied and frozen while awaiting results. However, the impact of repeated vitrification–warming cycles remains unclear due to confounding factors including biopsy effects, prior implantation failure, the absence of a true non-cryopreserved control, and fresh transfer comparisons confounded by supraphysiological hormonal exposure. STUDY DESIGN, SIZE, DURATION: To overcome the constraints of clinical studies, this study used the mouse as a controlled preclinical model. This allowed precise experimental control over embryo stage at cryopreservation and vitrification protocol and enabled direct comparison with a non-vitrified (fresh) control group without the confounding effects of supraphysiologic hormone exposure or biopsy. While species differences are recognized, this model enables focused assessment of cryopreservation-specific effects. Outcomes included post-warming survival, cell lineage allocation, as well as post embryo transfer outcomes on Day 18.5 of development (pregnancy and implantation rates, foetal and placental weights). Post-warming survival was assessed after one, two, or three freeze–warm cycles (3035, 1465, and 447 blastocysts, respectively; 23 independent experimental replicates). Inner cell mass (ICM) and trophectoderm (TE) cell numbers were quantified following one, two, or three freeze–warm cycles and compared to a fresh (non-vitrified) control (35, 36, 33, and 28 blastocysts, respectively; four independent experimental replicates). Post-transfer outcomes were evaluated after one, two, or three freeze–warm cycles and compared to a fresh (non-vitrified) control (30, 33, 39, and 22 pseudo-pregnant recipients, respectively). Sample size calculations were performed to ensure the study was appropriately powered. PARTICIPANTS/MATERIALS, SETTING, METHODS: Murine embryos were generated following IVF and cultured to the blastocyst stage, and underwent zero (fresh), one, two, or three repeated vitrification–warming cycles. Post-warming survival was assessed morphologically, and immunohistochemistry for OCT-3/4 (ICM) and CDX2 (TE) was used to assess cell lineage allocation. Embryo transfers were used to further evaluate developmental competence with pregnancy rate, implantation outcomes (implantation rate, viable implantation rate, resorption rate), foetal and placental outcomes (foetal weight, placental weight, and the foetal-to-placental weight ratio) measured on Day 18.5 of development. MAIN RESULTS AND THE ROLE OF CHANCE: Embryo cryosurvival declined significantly with increasing numbers of freeze–warm cycles, with marked reductions after two or three cycles compared with one cycle (P < 0.05) and a substantially higher proportion of non-viable embryos after three cycles (P < 0.001). ICM cell number was significantly reduced after two or three cycles compared with fresh embryos (P < 0.0001), while TE cell number increased after two cycles (P < 0.05). The ICM:TE ratio was significantly reduced after one, two, or three cycles compared with fresh (P < 0.01). Following embryo transfer, pregnancy rates were lower in all freeze–warm groups than in fresh controls, although these differences were not statistically significant. Relative risk of pregnancy compared with fresh transfer was 0.74 (95% CI 0.34–1.64) after one cycle, 0.75 (95% CI 0.35–1.62) after two cycles, and 0.59 (95% CI 0.27–1.32) after three cycles. Implantation and viable implantation rates showed similar nonsignificant reductions, while resorption rates were numerically higher after two or three freeze–warm cycles. Compared with the fresh group, foetal weights were significantly reduced after two and three cycles (P = 0.037 and P = 0.012), placental weight showed a nonsignificant trend towards increase, and the foetal:placental weight ratio was significantly decreased after two and three cycles (P = 0.009 and P = 0.002). While cryosurvival, ICM cell number, and foetal outcomes showed clear statistical effects, the nonsignificant pregnancy, implantation, and resorption measures indicate that chance may partly explain the post-transfer variability. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The study used a murine model, and although procedures reflected clinical practice, species differences mean further mechanistic and translational studies are needed to evaluate relevance to human reproduction. Additionally, the study focused exclusively on blastocyst-stage embryos, limiting the applicability of the findings to other developmental stages. The effects of cryoprotectant exposure alone were not investigated. WIDER IMPLICATIONS OF THE FINDINGS: These findings provide quantitative evidence of the cumulative effects of repeated embryo vitrification–warming and may inform optimization of cryopreservation protocols, limit unnecessary re-freezing, and support refinement of clinical guidelines to improve embryo viability and foetal outcomes in IVF. STUDY FUNDING/COMPETING INTEREST(S): K.R.D. is supported by an Australian Research Council Future Fellowship (Adelaide University, FT240100291). The authors declare that there is no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.